首页> 外文OA文献 >Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation
【2h】

Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation

机译:血管紧张素受体阻滞对心房颤动的心房电重构和“第二因子”的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atrial fibrillation (AF) is self-perpetuating, via mechanisms of acute electrical remodelling and 'second factors' acting over a longer time course. Renin-angiotensin system (RAS) blockade may inhibit AF self-perpetuation. We evaluated the effects of RAS blockade with candesartan in a burst-paced goat model of lone AF in which both mechanisms are known to operate. Bioactivity of oral candesartan was demonstrated in 10 goats by inhibition of the pressor effect of angiotensin II. The effects of candesartan on electrical remodelling were assessed in 12 placebo and 12 candesartan-treated goats in a 28-day burst pacing protocol. To assess the effects of candesartan on second factors (structural remodelling), 16 goats underwent further 28-day periods of burst pacing (two periods in 16 goats, three periods in eight goats) each separated by periods of sinus rhythm sufficient for electrical remodelling to reverse. There was a progressive rise in angiotensin levels in both groups. Candesartan (0.5 mg/kg/day) achieved a 76% blunting of the pressor effect of angiotensin II and had no effect on electrical remodelling; the half time for fall of atrial effective refractory period (AERP) was 22.3 ± 4.9 h (placebo) and 22.0 ± 3.2 h (candesartan) (p = ns). Candesartan had no effect on AF stability, which progressively increased over successive 28-day periods (ANOVA p <0.05). Candesartan had no effect on atrial electrical remodelling or the operation of 'second factors' in a goat model of lone AF. These findings suggest that any benefits of RAS blockade in patients with AF are unlikely to be due to direct effects on atrial remodelling. © The Authors, 2010.
机译:心房纤颤(AF)通过急性电重构和“第二因素”作用更长的时间过程而自我延续。肾素-血管紧张素系统(RAS)阻滞可能会抑制房颤的自我延续。我们评估了坎地沙坦的RAS阻断作用在孤立房颤的猝发起搏山羊模型中的作用,已知这两种机制均可起作用。通过抑制血管紧张素II的升压作用,在10只山羊中证明了口服坎地沙坦的生物活性。在28天的突发起搏方案中,在12只安慰剂和12只经坎地沙坦治疗的山羊中评估了坎地沙坦对电重构的影响。为了评估坎地沙坦对第二因素(结构重塑)的影响,对16只山羊进行了进一步的28天连续起搏(16个山羊为2个周期,八个山羊为3个周期),每个周期之间的窦性心律足以进行电重塑。逆转。两组的血管紧张素水平均逐渐升高。坎地沙坦(0.5 mg / kg /天)使血管紧张素II的升压作用减弱了76%,并且对电重构没有影响。心房有效不应期(AERP)下降的半衰期为22.3±4.9 h(安慰剂)和22.0±3.2 h(坎地沙坦)(p = ns)。坎地沙坦对房颤稳定性无影响,在连续28天的时间内房颤稳定性逐渐增加(ANOVA p <0.05)。坎地沙坦对孤立性AF山羊模型的心房电重构或“第二因子”的操作没有影响。这些发现表明,RAS阻滞对房颤患者的任何益处均不太可能归因于对心房重构的直接影响。 ©作者,2010年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号